Laser endoscopic surgery, especially the effectiveness of photodynamic therapy (PDT) using Photofrin as a photosensitizer, has now achieved a status as effective treatment modality for lung cancer. Twenty-six lung cancer patients received the preoperative PDT for the purpose of either reducing the extent of resection or increasing operability. Bronchoscopical PDT is performed with topical anesthesia approximately 48h after the intravenous injection of 2.0 mg/kg body weight of Photofrin. Operation was performed 2-9 weeks after initial PDT.
INTRODUCTION
Laser endoscopic surgery has now achieved a status as effective treatment modality for lung cancer. Especially increasing attention has been focused on photodynamic therapy (PDT) using Photofrin. Over the past decade, 248 patients (296 lesions) with central type lung cancers have been treated in our hospital. Overall complete remission (CR) was obtained in 42.5% of the 125 lesions, partial remission (PR) in 56.8% and no remission was obtained in 1.0% [1] . Indications of PDT are as follows: (1) [2] . (2) Advanced lesions for opening of bronchi: overall, "effective" opening of bronchi was achieved in 61 out of 81 lesions (75%) for the PDT group, as opposed to 143 of 177 (81%) for the Nd-YAG laser therapy group [3] . 156 T. OKUNAKA et al. (3) Preoperative laser irradiation for the purpose of increasing operability and reducing the extent of operation: the initial purpose of PDT, i.e., either reduction of extent of resection or conversion of inoperable disease to operable status, was achieved in 11 out of 15 patients treated [4] . (4) Multiple primary lung cancer [5] .
In Japan, PDT for early stage bronchogenic carcinoma is most common and its indications have already been determined [6] . However, in spite of the recent advances in the diagnostic techniques and establishment of the mass screening system, most lung cancers are still detected in the advanced stage.
As would be expected, better therapeutic results were obtained in all resected cases of lung cancer than in nonresected cases [7] . [9] . After PDT procedure, bronchial toilet should be performed every 2 or 3 days for week. The effectiveness ofPDT was evaluated both bronchoscopically and histologically 2 weeks after the PDT, and operation was performed 2-9 weeks after the PDT. A typical case of squamous cell carcinoma of the lung is shown in Fig. 2 . The patient, a 51-year-old male, had a polypoid tumor obstructing the orifice of the right main bronchus with invasion to the lateral wall of the trachea and truncus intermedius. This tumor was initially considered inoperable and treated with PDT. Later on, the base of the tumor invasion in the lateral part ofthe trachea and truncus intermedius disappeared following PDT. Subsequently, upper sleeve lobectomy could be done 6 weeks after PDT.
RESULTS
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DISCUSSION
The past decade has seen a growing acceptance of PDT, a relatively new modality used in the treatment of cancer. This method has been used to treat a wide variety of malignancies in over 3000 patients worldwide. Approximately 90 institutions and 180 investigators throughout the world employ PDT. Five hundred patients have undergone PDT for endobronchial malignancy. There has been remarkable consistency in results of various investigator, showing CR + PR rates ranging from 70% to 100% [10] .
In Japan, PDT with Photofrin and excimer dye laser obtained government approval in October 1994 and finally obtained national insurance reimbursement status in April 1996 11].
In our basic studies with PDT, at least cm tumor necrosis was noted in all the cases [12] . This observational study lead us to use PDT preparatively to reduce the extent of the surgical resection and convert inoperable cases to operable ones. In our present study, the objective ofpreoperative PDT which were initially planned for pneumonectomy underwent successful lobectomy. However, 3 of them subsequently died as a result of distant metastasis, and in 2 other cases, recurrence was recognized. These results indicate the need for an accurate determination of the status of the patients before PDT. In terms of selecting patients for the procedure, endoscopic observation, brushing and biopsy are important. These examinations should confirm that the lesion is invading superficially, in which case the histological type is generally squamous cell carcinoma.
In our hospital, the T3 (main bronchus invasion) cases normally underwent surgery with a survival rate of 50.9%. In our present study, the T3 (main bronchus invasion) NOM0 cases which were planed initially for pneumonectomy underwent preoperative PDT and subsequently underwent lobectomy.
The survival rate in this group of patients remarkably increased to 60.0%. Despite the fact that the number of cases in this study was limited, the result is very inspiring for further study.
Various attempts have been made to develop methods to improve the condition of lung cancer patients so that the extent ofresection can be limited. These include preoperative systemic chemotherapy, bronchial arterial infusion [13] and preoperative radiotherapy [14] . Owing 
